Alliance Pharma plc (APH.L)
GBp 64.6
(0.16%)
GBp 64.6
(0.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 21.97 Million | 20.97 Million | 38.65 Million | 41.56 Million | 35.75 Million | 22.17 Million |
| Net Income | -33.13 Million | 936 Thousand | 7.31 Million | 8.02 Million | 25.01 Million | 18.35 Million |
| Depreciation & Amortization | 10.32 Million | 10.76 Million | 16.25 Million | 20.96 Million | 1.95 Million | 7.79 Million |
| Deferred income taxes | -20.66 Million | -1.5 Million | 4.37 Million | 1.1 Million | 3.81 Million | 870 Thousand |
| Stock-based compensation | 889 Thousand | 92 Thousand | 2.25 Million | 1.37 Million | 1.81 Million | 1.79 Million |
| Change in working capital | -14.18 Million | -14.72 Million | 4.83 Million | 7.45 Million | -2.26 Million | -10.04 Million |
| Other non-cash items | 106.69 Million | 25.41 Million | 3.62 Million | 2.64 Million | 5.42 Million | 3.4 Million |
| Investing Cash Flow | -918 Thousand | -17.02 Million | -4.59 Million | -85.86 Million | -3.28 Million | -59.08 Million |
| Investments in PPE | -696 Thousand | -607 Thousand | -5.53 Million | -4.61 Million | -4.15 Million | -2.93 Million |
| Acquisitions | -222 Thousand | -16.61 Million | 183 Thousand | -82.66 Million | 500 Thousand | -58.61 Million |
| Investment purchases | - | - | - | - | -500 Thousand | -3.62 Million |
| Sales/Maturities of investments | - | - | - | - | 500 Thousand | 3.62 Million |
| Other Investing Activities | - | 200 Thousand | 750 Thousand | 1.41 Million | 373 Thousand | 2.46 Million |
| Financing Cash Flow | -29.76 Million | -876 Thousand | -34.34 Million | 55.74 Million | -25.19 Million | 36.58 Million |
| Debt repayment | -19.33 Million | -1.26 Million | -22.58 Million | -21.54 Million | -18.53 Million | -15.81 Million |
| Dividends payments | -9.59 Million | -9.11 Million | -8.6 Million | -2.83 Million | -7.59 Million | -6.34 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 37 Thousand | 341 Thousand | 736 Thousand | 1.64 Million | 4.5 Million | 34.81 Million |
| Other Financing Activities | -11.63 Million | 9.16 Million | -3.88 Million | 78.48 Million | -3.57 Million | 23.92 Million |
| Accounts receivables | -6.48 Million | -18.72 Million | -6.14 Million | 6.72 Million | -498 Thousand | -7.62 Million |
| Accounts payables | 1.93 Million | 7.28 Million | -326 Thousand | 5.92 Million | -3.8 Million | 5.05 Million |
| Inventory | -1.85 Million | -2.2 Million | 1.84 Million | -5.2 Million | 2.03 Million | -4.45 Million |
| Other working capital | -7.78 Million | -1.07 Million | 9.46 Million | - | - | -3.01 Million |
| Cash at beginning of period | 31.71 Million | 29.06 Million | 28.89 Million | 17.83 Million | 10.89 Million | 11.18 Million |
| Cash at end of period | 22.43 Million | 31.71 Million | 29.06 Million | 28.89 Million | 17.83 Million | 10.89 Million |
| Capital Expenditure | -696 Thousand | -607 Thousand | -5.53 Million | -4.61 Million | -4.15 Million | -2.93 Million |
| Effect of forex changes on cash | -577 Thousand | -418 Thousand | 447 Thousand | -384 Thousand | -339 Thousand | 34 Thousand |
| Net cash flow / Change in cash | -9.27 Million | 2.65 Million | 163 Thousand | 11.06 Million | 6.93 Million | -291 Thousand |
| Free Cash Flow | 21.28 Million | 20.36 Million | 33.12 Million | 36.95 Million | 31.6 Million | 19.23 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.66 Million | -33.13 Million | -38.24 Million | 5.1 Million | 936 Thousand | -12.16 Million |
| Depreciation & Amortization | 4.83 Million | 10.32 Million | 5.56 Million | 4.76 Million | 10.76 Million | 5.42 Million |
| Deferred income taxes | - | -20.66 Million | -20.66 Million | - | -1.5 Million | -1.5 Million |
| Stock-based compensation | - | 889 Thousand | - | - | 92 Thousand | - |
| Change in working capital | -939 Thousand | -14.18 Million | -14.01 Million | -174 Thousand | -14.72 Million | -202 Thousand |
| Other non-cash items | 953 Thousand | 106.69 Million | 95.53 Million | 11.16 Million | 25.41 Million | 28.95 Million |
| Investing Cash Flow | -728 Thousand | -918 Thousand | -512 Thousand | -406 Thousand | -17.02 Million | -993 Thousand |
| Investments in PPE | -728 Thousand | -696 Thousand | -497 Thousand | -199 Thousand | -607 Thousand | -55 Thousand |
| Acquisitions | - | -222 Thousand | -15 Thousand | -207 Thousand | -16.61 Million | -938 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 200 Thousand | - |
| Financing Cash Flow | -11.63 Million | -29.76 Million | -14.05 Million | -15.7 Million | -876 Thousand | -6.51 Million |
| Debt repayment | -11.21 Million | -19.33 Million | -7.23 Million | -12.1 Million | -1.26 Million | - |
| Dividends payments | - | -9.59 Million | -6.39 Million | -3.19 Million | -9.11 Million | -6.08 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 20 Thousand | 37 Thousand | 3000.00 | 34 Thousand | 341 Thousand | 51 Thousand |
| Other Financing Activities | -435 Thousand | - | -425 Thousand | -442 Thousand | 9.16 Million | -483 Thousand |
| Accounts receivables | 8.85 Million | -6.48 Million | -14.81 Million | 8.33 Million | -18.72 Million | -4.3 Million |
| Accounts payables | -7.92 Million | 1.93 Million | 7.63 Million | -5.69 Million | 7.28 Million | 6.43 Million |
| Inventory | -1.86 Million | -1.85 Million | 951 Thousand | -2.81 Million | -2.2 Million | -1.25 Million |
| Other working capital | - | -7.78 Million | -7.78 Million | - | -1.07 Million | -1.07 Million |
| Cash at beginning of period | 22.43 Million | 31.71 Million | 26.11 Million | 31.71 Million | 29.06 Million | 29.38 Million |
| Cash at end of period | 19.27 Million | 22.43 Million | 22.43 Million | 26.11 Million | 31.71 Million | 31.71 Million |
| Capital Expenditure | -728 Thousand | -696 Thousand | -497 Thousand | -199 Thousand | -607 Thousand | -55 Thousand |
| Effect of forex changes on cash | - | -577 Thousand | - | -650 Thousand | -418 Thousand | -682 Thousand |
| Net cash flow / Change in cash | -3.16 Million | -9.27 Million | -3.67 Million | -5.6 Million | 2.65 Million | 2.33 Million |
| Free Cash Flow | 8.78 Million | 21.28 Million | 10.32 Million | 10.96 Million | 20.36 Million | 10.47 Million |
SZLMY
8137
FERRO
KCM
TRUE
688538